G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2011
12/29/2011	US20110319601 Inorganic Particle Conjugates
12/29/2011	US20110319499 Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease
12/29/2011	US20110319475 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
12/29/2011	US20110319474 siRNA targeting cyclin-dependent kinase 4 (CDK4)
12/29/2011	US20110319470 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
12/29/2011	US20110319465 Estrogen receptor modulators and uses thereof
12/29/2011	US20110319415 Susceptibility to HSP90-Inhibitors
12/29/2011	US20110319372 Method of diagnosing and therapeutically treating a patient for a traumatic brain injury
12/29/2011	US20110319339 Neurotensin-derived branched peptides and uses thereof
12/29/2011	US20110319337 Dominant Negative WNT2 Compositions and Methods of Use
12/29/2011	US20110319336 Selective anticancer chimeric peptide
12/29/2011	US20110319334 Compositions and methods for prevention and treatment of neurodegenerative diseases
12/29/2011	US20110319333 Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
12/29/2011	US20110319327 Polypeptides Homologous to VEGF and BMP1
12/29/2011	US20110319293 Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay
12/29/2011	US20110319287 Modulator assay
12/29/2011	US20110319286 System for screening agonists/antagonists of cellular signaling pathways
12/29/2011	US20110319280 Ect2 oncogene as a therapeutic target and prognostic indicator for lung and esophageal cancer
12/29/2011	US20110319278 Encoded self-assembling chemical libraries (esachel)
12/29/2011	US20110319277 Prpk-tprkb modulators and uses thereof
12/29/2011	US20110319274 Identification of Compounds Modifying a Cellular Response
12/29/2011	US20110318847 Cvd assay
12/29/2011	US20110318846 Aptamer and detection method for C-reactive protein
12/29/2011	US20110318845 Sample analyzer and liquid aspirating method
12/29/2011	US20110318834 Multiple-tumor aberrant growth genes
12/29/2011	US20110318832 Human Telomerase Catalytic Subunit
12/29/2011	US20110318825 In situ heat induced antigen recovery and staining apparatus and method
12/29/2011	US20110318821 Bioagent detection methods
12/29/2011	US20110318771 Deuterium isobaric tag reagents for quantitative analysis
12/29/2011	US20110318767 Method for Measuring Plasma Glucose
12/29/2011	US20110318766 Arginine vasopressin pro-hormone as predictive biomarker for diabetes
12/29/2011	US20110318765 Method for pre-treating sample containing glycated hemoglobin
12/29/2011	US20110318764 Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases
12/29/2011	US20110318763 Detection of cancer by elevated levels of bcl-2
12/29/2011	US20110318762 Graft-Versus-Host Disease Predicting Marker and Use Thereof
12/29/2011	US20110318761 Methods and kits for predicting a response to an erythropoietic agent
12/29/2011	US20110318760 Method for the in vitro diagnosis of an autoimmune response associated with the existence of an antineutrophil cytoplasmic antibodies-associated vasculitis by detection of antibodies directed against the pentraxin 3 antigen
12/29/2011	US20110318759 Method for assaying keratan sulfate, assay kit therefor and method for detecting joint disease by using the same
12/29/2011	US20110318758 Human monoclonal antibodies and methods for producing the same
12/29/2011	US20110318757 Recombinant anti-muc1 antibodies
12/29/2011	US20110318756 Small specimen staining and diagnosing of cells
12/29/2011	US20110318755 Universal Testing Platform for Medical Diagnostics
12/29/2011	US20110318754 Reduction in False Results in Assay Measurements
12/29/2011	US20110318753 New compound, phosphorylation inhibitor, insulin resistance improving agent, preventive or therapeutic agent for diabetes, and screening method
12/29/2011	US20110318751 PUMA, A PRO-APOPTOTIC GENE, AS A NOVEL MOLECULAR BIOMARKER FOR TNFalpha-INDUCED HUMAN ISLET DAMAGE
12/29/2011	US20110318749 Method for identifying regulatory t cells
12/29/2011	US20110318746 Rapid oligo probes
12/29/2011	US20110318745 Compositions and methods for performing hybridizations with separate denaturation of the sample and probe
12/29/2011	US20110318741 Biomarkers for the treatment of psoriasis
12/29/2011	US20110318730 Micropatterned co-culture systems as infectious disease analysis platforms
12/29/2011	US20110318726 Predicting coronary artery disease and risk of cardiovascular events
12/29/2011	US20110318389 Human pancreatic beta cell lines for diagnostic of diabetes
12/29/2011	US20110318380 MHC Multimers in Cancer Vaccines and Immune Monitoring
12/29/2011	US20110318371 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
12/29/2011	US20110318370 Cxcl4l1 as a biomarker of pancreatic cancer
12/29/2011	US20110318369 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2011	US20110318367 Novel targets for treatment of hypercholesterolemia
12/29/2011	US20110318365 Methods for treatment of degenerative disease associated with apoptosis
12/29/2011	US20110318362 Novel card proteins involved in cell death regulation
12/29/2011	US20110318361 Anticancer Drug Comprising Inhibitor of Tmprss4
12/29/2011	US20110318357 Methods and compositions based on shiga toxin type 2 protein
12/29/2011	US20110318355 Mutant proteins of the f protein of piv-5 and piv-2
12/29/2011	US20110318351 Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
12/29/2011	US20110318349 Dual variable domain immunoglobulins and uses thereof
12/29/2011	US20110318344 Tumor Treatment
12/29/2011	US20110318308 Lipocalin-type prostaglandin d2 synthase as a biomarker for lung cancer progression and prognosis
12/29/2011	US20110318304 Detection of epha3 as a marker of the presence of a solid tumor
12/29/2011	US20110318301 Il-17a/f heterologous polypeptides and therapeutic uses thereof
12/29/2011	US20110318274 Variant of mite allergen and uses thereof
12/29/2011	US20110318270 Drug identification protocol for type 2 diabetes based on gene expression signatures
12/29/2011	US20110318269 Method For Screening Phage Display Libraries Against Each Other
12/29/2011	US20110318266 Phthalimide derivative metabotropic glutamate r4 ligands
12/29/2011	US20110318264 Methods and compositions for diagnosis and treatment of cancer
12/29/2011	US20110318227 Switches for microfluidic systems
12/29/2011	US20110318226 Calibration slide for fluorescence detection instruments and process of preparation
12/29/2011	US20110315962 Nanosensors
12/29/2011	US20110315930 Compositions and methods for analyzing biomolecules using mass spectroscopy
12/29/2011	US20110315625 Detection of micro-organisms
12/29/2011	US20110315552 Systems and Methods for Discovery and Analysis of Markers
12/29/2011	US20110315551 Electrode for active oxygen species and sensor using the electrode
12/29/2011	US20110315549 Testing strip for detecting a fluidic sample
12/29/2011	US20110315548 Biological signal detection electrode and biological signal detection apparatus
12/29/2011	US20110314903 Body fluid testing device
12/29/2011	US20110314897 Gas sensing using ultrasound
12/29/2011	US20110314896 Method for testing the function of a device
12/29/2011	US20110314895 Method of testing a soil specimen
12/29/2011	US20110314892 Method and device for the dynamic monitoring of a lambda probe
12/29/2011	DE19937318B4 Nachkalibrierverfahren und zugehöriges Gasanalysegerät zur qualitativen und/oder quantitativen Bestimmung einer Gaskonzentration Recalibration and associated gas analyzer for the qualitative and / or quantitative determination of a gas concentration
12/29/2011	DE10392159B4 Biosensor, Biosensorchip und Biosensoreinrichtung Biosensor, biosensor chip and biosensor
12/29/2011	DE102010025545A1 Verfahren zum Nachweis von L-PK-Tumormarkern in Körperflüssigkeiten, insbesondere im Stuhl zur Erkennung von Lebererkrankungen A method for detection of L-PK tumor markers in body fluids, especially in the chair for the detection of liver diseases
12/29/2011	DE102006016822B4 Volumenbestimmung von Gewässern Volume determination of water
12/29/2011	DE102005057088B4 Verfahren und Vorrichtung zur Prüfung der Qualität einer Klebeverbindung zwischen einer Platte oder Scheibe und einem Rahmen Method and device for testing the quality of an adhesive connection between a plate or disk and a frame
12/29/2011	DE10041227B4 Vorrichtung zur Behandlung von Objekten Device for treatment of objects
12/29/2011	CA2841142A1 Biomarkers for non-hodgkin lymphomas and uses thereof
12/29/2011	CA2805025A1 Method and apparatus for detecting and regulating vascular endothelial growth factor (vegf) by forming a homeostatic loop employing a half-antibody biosensor
12/29/2011	CA2804297A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
12/29/2011	CA2803865A1 Methods for detecting cancer
12/29/2011	CA2803694A1 Method for the characterization of intermolecular interactions
12/29/2011	CA2803500A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
12/29/2011	CA2803498A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

1 ... 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 ... 3937